Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025)

Arcturus Therapeutics Holdings' Treasury Shares history spans 5 years, with the latest figure at $18786.0 for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $18786.0; the TTM value through Dec 2025 reached $18786.0, changed 0.0%, while the annual FY2025 figure was $18786.0, 0.0% changed from the prior year.
  • Treasury Shares reached $18786.0 in Q4 2025 per ARCT's latest filing, roughly flat from $18786.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $18786.0 in Q4 2023 to a low of $18786.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $18786.0, with a median of $18786.0 recorded in 2023.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $18786.0 in 2023, then changed by 0.0% to $18786.0 in 2024, then changed by 0.0% to $18786.0 in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Treasury Shares are $18786.0 (Q4 2025), $18786.0 (Q4 2024), and $18786.0 (Q4 2023).